Wellington Management Group LLP Heron Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 496,227 shares of HRTX stock, worth $530,962. This represents 0.0% of its overall portfolio holdings.

Number of Shares

496,227

Previous 521,194 4.79%

Holding current value

$530,962

Previous $1.82 Million 45.89%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.73 - $3.67 $43,192 - $91,628	-24,967 Reduced 4.79%	496,227 $987,000
Q2 2024 Aug 13, 2024	BUY	$2.32 - $3.86 $239,444 - $398,386	103,209 Added 24.69%	521,194 $1.82 Million
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $714,754 - $1.28 Million	417,985 New	417,985 $1.16 Million
Q1 2023 May 12, 2023	SELL	$1.51 - $3.25 $21,695 - $46,696	-14,368 Reduced 4.4%	312,286 $471,000
Q4 2022 Feb 13, 2023	SELL	$2.25 - $4.67 $14,078 - $29,220	-6,257 Reduced 1.88%	326,654 $816,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $241,214 - $486,962	-90,682 Reduced 21.41%	332,911 $1.4 Million
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $3 Million - $8.22 Million	-1,306,179 Reduced 75.51%	423,593 $1.18 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $423,640 - $909,500	91,499 Added 5.59%	1,729,772 $9.89 Million
Q4 2021 Feb 11, 2022	SELL	$8.35 - $12.6 $6.55 Million - $9.88 Million	-784,149 Reduced 32.37%	1,638,273 $15 Million
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $18.2 Million - $27 Million	-1,799,267 Reduced 42.62%	2,422,422 $25.9 Million
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $21.6 Million - $30 Million	-1,625,659 Reduced 27.8%	4,221,689 $65.5 Million
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $15.8 Million - $22.6 Million	-1,088,566 Reduced 15.69%	5,847,348 $94.8 Million
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $48.5 Million - $73.6 Million	3,322,618 Added 91.96%	6,935,914 $147 Million
Q3 2020 Nov 16, 2020	BUY	$13.67 - $17.77 $6.67 Million - $8.68 Million	488,201 Added 15.62%	3,613,296 $53.6 Million
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $7.46 Million - $14.7 Million	685,099 Added 28.08%	3,125,095 $46 Million
Q1 2020 May 14, 2020	SELL	$10.23 - $24.56 $21.1 Million - $50.5 Million	-2,057,833 Reduced 45.75%	2,439,996 $28.6 Million
Q4 2019 Feb 11, 2020	BUY	$17.42 - $26.61 $78.4 Million - $120 Million	4,497,829 New	4,497,829 $106 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Heron Therapeutics, Inc. Transaction History